Express Pharma

JUNE 21, 2024

Additionally, the Department of Pharmaceuticals, Government of India, directive requires strict compliance with the Uniform Code for Marketing Practices 2024. The ‘Pradhan Mantri Bhartiya Janaushadhi Pariyojana’ (9) promotes retail outlets to provide quality generic medicines at affordable prices.

Generic Medicine 102

Generic Medicine Vaccines Diabetes Immunity 102

Express Pharma

MARCH 20, 2025

Over the past decade and more, Indias pharmaceutical sector has become the worlds largest supplier of generic medicines, with exports growing faster than the global average. References BMI, a Fitch solutions company, 2024. Generic Drug Facilities, Sites, and Organization Lists; Department of Science and Technology.

Generic Medicine 66

Generic Medicine Dosage Packaging 66

Express Pharma

NOVEMBER 15, 2024

Integrating ESG considerations into core pharma operations India, known as the “Pharmacy of the World,” produces over 20 per cent of the global supply of generic medicines and plays a vital role in vaccine production, as per the Investindia.gov.in It meets the healthcare needs of over 1.4

Packaging 102

Packaging Generic Medicine Pharmaceutical Manufacturing Vaccines 102

Quality Matters

APRIL 18, 2024

josh.levin@usp.org Thu, 04/18/2024 - 12:57 USP Leadership In addition, they are more compact and 44% lighter than previous versions, on average. Changes include replacing previously used expanded polystyrene (EPS) thermoplastic foam components with 100% recycled fiber inserts. These USP documentary standards are recognized in U.S.

Pharmaceutical Manufacturing 59

Pharmaceutical Manufacturing Packaging Generic Medicine 59

Quality Matters

MAY 30, 2024

In response to this pervasive public health crisis and to maintain momentum toward action, USP and ACS CAN hosted a Congressional briefing in March 2024 to highlight the root causes, complexities, and pervasiveness of drug shortages, as well as the need for urgent and comprehensive solutions.

Generic Medicine 50

Generic Medicine Hospitals Vaccines 50

European Pharmaceutical Review

FEBRUARY 26, 2024

At its February 2024 meeting, the EMA’s human medicines committee (CHMP) recommended the extension of marketing authorisations for six treatments, and positive opinions for the approval of ten medicines. These products were designated as an orphan medicine during their development.

Generic Medicine 98

Generic Medicine Vaccines Pharmaceutical Companies Pharmaceutical Companies 98

Express Pharma

MARCH 12, 2025

The FDA has an established office in India overseeing the number of qualified manufacturers supplying generic medicines to the US. Inspection categorisation of Official Action Indicated (OAI) for Indian companies has decreased to 11 per cent in 2024 from 23 per cent in 2014, aligning with the global trend of 14 per cent in 2024.

Generic Medicine 66

Generic Medicine Process Improvement Dosage Pharmaceutical Manufacturing 66

Express Pharma

FEBRUARY 14, 2024

. “If accepted, these IP provisions will have drastic consequences on access to medicines and the health of patients in India and beyond. Millions of lives depend on India putting people’s health first and being able to continue supplying generic medicines globally,” according to Dr Mantoo.

Generic Medicine 103

Generic Medicine Vaccines 103

European Pharmaceutical Review

APRIL 30, 2024

The committee also recommended the biosimilar medicine Wezenla (ustekinumab) to treat of plaque psoriasis. Generic medicine Eribulin Baxter (eribulin) was also granted a positive opinion by the committee, to treat breast cancer and liposarcoma. This covers paediatric plaque psoriasis, psoriatic arthritis and Crohn’s disease.

Biosimilars 98

Biosimilars Generic Medicine Chemotherapy Hospitals 98

European Pharmaceutical Review

JULY 29, 2024

These medicines were recommended by the CHMP to treat plaque psoriasis, paediatric plaque psoriasis, psoriatic arthritis, ulcerative colitis and Crohn’s disease. The post CHMP meeting highlights – July 2024 appeared first on European Pharmaceutical Review. Tuznue (trastuzumab) for breast and gastric cancer.

Generic Medicine 52

Generic Medicine Biosimilars 52

European Pharmaceutical Review

JANUARY 30, 2024

The European Medicine Agency’s human medicines committee (CHMP) recommended marketing authorisations for the regulatory approval of three medicines at its January 2024 meeting last week. Additionally, a positive opinion for Niapelf (paliperidone), a generic medicine for schizophrenia was adopted in the meeting.

Generic Medicine 98

Generic Medicine Chemotherapy Hospitals 98

PharmaState Academy

JANUARY 29, 2024

PharmaState.Academy organized a ‘Masterclass for International Pharmaceutical Marketing’ enthusiasts on January 28, 2024. He highlighted potential opportunities due to the low cost of skilled labor, expanding market size, and increasing global demand for generic drugs.

Generic Medicine 52

Generic Medicine Packaging 52

Express Pharma

MARCH 3, 2025

According to him, Passing the PILLS Act is a necessary first step to reverse this trend, restore American pharmaceutical production, create high-quality jobs, and protect national security by ensuring a safe, reliable domestic supply of high-quality generic medicines, antibiotics, and other essential drugs.” Sounds familiar?

Generic Medicine 87

Generic Medicine Biosimilars 87

Pharmaceutical Technology

DECEMBER 19, 2022

by the end of 2023 and may continue to rise in 2024 to 5%. Joy Polefrone, the executive director of the organization, says it aims to build a cluster of partners who are capable of manufacturing generic medicines. JP Morgan predicts that the US unemployment rate could rise to 4.3%

Pharmaceutical Companies 69

Pharmaceutical Companies Pharmaceutical Companies Pharmaceutical Manufacturing Generic Medicine 69

European Pharmaceutical Review

FEBRUARY 3, 2025

Additionally, the CHMP recommended the generic medicine Eltrombopag Accord (eltrombopag) to treat primary immune thrombocytopenia and thrombocytopenia associated with chronic hepatitis C. The EC questioned whether this would necessitate an update of the CHMPs opinion made in November 2024.

Vaccines 52

Vaccines Generic Medicine Chemotherapy Biosimilars 52